Hepatic Impairment After oral administration of one 4 mg dose (2 mg hydromorphone quick-release tablets), mean exposure to hydromorphone (Cmax and AUC∞) is amplified four-fold in individuals with average (Little one-Pugh Team B) hepatic impairment in comparison with topics with normal hepatic functionality. Resulting from increased publicity o… Read More